KalVista Pharmaceuticals, Inc. ($KALV)
Filing Information
| Accession Number | 0001298146-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 11, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
91,000
Total Value
$0.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 14,000 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 7,000 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 10,000 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 10,000 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 10,000 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 10,000 | โ | โ | 0 | Direct | โ | View Details | |
Director | Stock Option (Right to Buy) | Derivative | Jun 11, 2026 | Sale to Issuer | 30,000 | โ | โ | 0 | Direct | โ | View Details |